Last $33.89 USD
Change Today +0.50 / 1.50%
Volume 33.8K
ENTA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 11:13 AM 04/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jack S. Remington M.D., FACP, FRCP

AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 3 different industries.

See Board Relationships
82--

Background*

Dr. Jack S. Remington, MD, FACP, FRCP serves as Clinical Advisor of Enanta Pharmaceuticals Inc. Dr. Remington serves as the Chairman of the Department of Immunology and Infectious Diseases at the Research Institute of the Palo Alto Medical Foundation for nearly four decades. He served as President of the Infectious Disease Society of America. He served as the head of the Research Institute's Department of Immunology and Infectious Diseases nearly four decades. In addition, ...

Read Full Background

Corporate Headquarters*

500 Arsenal Street
Watertown, Massachusetts 02472

United States

Phone: 617-607-0800
Fax: 617-607-0530

Board Members Memberships*

1996-N/A
Former Director
1996-2011
Former Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee

Education*

BS
University of Illinois-Urbana-Champaign
MD
University of Illinois-Urbana-Champaign
Unknown/Other Education
University of California

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENTA:US $33.89 USD +0.50

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENANTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.